Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-24T02:32:27.809Z Has data issue: false hasContentIssue false

Case 28 - A 34-Year-Old G2P1 Woman with Elevated β-hCG (>250 000 mIU/mL) and Concern for Molar Gestation

Published online by Cambridge University Press:  19 November 2021

By
Maria Shaker
Edited by
Todd R. Jenkins ,
Lisa Keder ,
Abimola Famuyide ,
Kimberly S. Gecsi  and
David Chelmow
Todd R. Jenkins
Affiliation:
University of Alabama, Birmingham
Lisa Keder
Affiliation:
Ohio State University School of Medicine, Columbus
Abimola Famuyide
Affiliation:
Mayo Clinic, Rochester
Kimberly S. Gecsi
Affiliation:
Medical College of Wisconsin
David Chelmow
Affiliation:
Virginia Commonwealth University School of Medicine
Get access

Summary

A healthy 34-year-old woman, gravida 2, para 1001, last menstrual period (LMP) approximately nine weeks ago presents with vaginal spotting. She reports nausea and vomiting for three weeks. Her menstrual cycles are normal in length, and she is sure of her LMP. She reports a history of a normal pregnancy that resulted in an uncomplicated spontaneous vaginal delivery two years ago. She has no relevant past medical or surgical history. She is currently taking prenatal vitamins and has no known drug allergies.

Type
Chapter
Information
Surgical Gynecology
A Case-Based Approach
 , pp. 82 - 84
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albright, BB, Shorter, JM, Mastroyannis, SA, et al. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization following molar pregnancy: a systematic review and meta-analysis. Obstet Gynecol 2020; 135: 12–23.CrossRefGoogle ScholarPubMed
Lurain, JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 2010; 203(6): 531–9. doi:10.1016/j.ajog.2010.06.073.CrossRefGoogle ScholarPubMed
Padrón, L, Rezende Filho, J, Amim Junior, J, et al. Manual compared with electric vacuum aspiration for treatment of molar pregnancy. Obstet Gynecol 2018; 131(4): 652–9.CrossRefGoogle ScholarPubMed
Berkowitz, RS, Horowitz, NS, Elias, K. Hydatidiform mole: treatment and follow-up. In: Goff, B, ed., UpToDate. Available at: www.uptodate.com/contents/hydatidiform-mole-treatment-and-follow-up?search=hydatidiform%20mole&source=search_result&selectedTitle=1~48&usage_type=default&display_rank=1. (Accessed July 24, 2020.)Google Scholar
Ngan, HYS, Seckl, MJ, Berkowitz, RS, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet 2018; 143(Suppl 2): 79–85.CrossRefGoogle ScholarPubMed
Gaffield, ME, Kapp, N, Curtis, KM. Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease. Contraception 2009; 80(4): 363–71. doi:10.1016/j.contraception.2009.03.022.CrossRefGoogle ScholarPubMed
World Health Organization. Medical eligibility criteria for contraceptive use, 5th ed. 2015. Available at: https://apps.who.int/iris/bitstream/handle/10665/181468/9789241549158_eng.pdf?sequence=9 (Accessed July 24, 2020).Google Scholar
Curtis, KM, Tepper, NK, Jatlaoui, TC, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016; 65(3): 1–103. doi:10.15585/mmwr.rr6503a1.Google ScholarPubMed
Berkowitz, RS, Goldstein, DP. Clinical practice. Molar pregnancy. N Engl J Med 2009; 360(16): 1639–45. doi:10.1056/NEJMcp0900696.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×